Reed Jobs on how his venture firm tackles cancer | TechCrunch

Reed Jobs' fund for cancer-fighting biotech, Yosemite , launched in August with $200 million in funding from investors like MIT , Memorial Sloan Kettering Cancer Center and John Doerr .

Jobs first became interested in oncology as a teen after his father, Steve Jobs , was diagnosed with pancreatic cancer.

Jobs is optimistic about the development of next-generation therapies, including immunotherapies and gene-editing therapies, and how quickly they can develop.

Yosemite launched last month .

Jobs has been making investments through Emerson Collective for eight years .

He has invested in Yale , Yale and Tune Therapeutics in the epigenetic editing space.

Jobs is optimistic about the progress being made in developing new treatments for cancer.

“I’m all for being ambitious. Biotech is never as linear as tech, it’s always abounds in mystery and difficulty, which can be very exciting”.